TY - JOUR
T1 - Histone deacetylase-6 modulates the effects of 4◦C platelets on vascular endothelial permeability
AU - Miyazawa, Byron
AU - Trivedi, Alpa
AU - Vivona, Lindsay
AU - Lin, Maximillian
AU - Potter, Daniel
AU - Nair, Alison
AU - Barry, Mark
AU - Cap, Andrew P.
AU - Pati, Shibani
N1 - Publisher Copyright:
© 2023 American Society of Hematology. All rights reserved.
PY - 2023/4
Y1 - 2023/4
N2 - Platelets (PLTs) stored at 4◦C exhibit equivalent or superior hemostatic function compared with 22◦C PLTs, but have shorter circulation times and a decreased ability to modulate vascular permeability. These differences may be due to morphological changes and storage-induced activation. Using a proteomics-based approach, we found that 4◦C-stored PLTs express decreased α-tubulin, a key PLT structural protein. PLT activation is characterized by α-tubulin deacetylation, which is regulated by histone deacetylase-6 (HDAC-6). We hypothesized that inhibition of HDAC-6 in stored PLTs will improve their ability to regulate vascular permeability through reduced activation and α-tubulin deacetylation. In an in vivo model of vascular permeability, treatment of 4◦C PLTs with the HDAC-6 inhibitor tubacin enhanced the vasculoprotective properties of untreated 4◦C PLTs. 4◦C PLT circulation, however, was unchanged by tubacin treatment, suggesting that circulation time may not be a critical factor in determining the vasculoprotective effects of PLTs. Assessing the factor content of stored PLTs revealed that angiopoietin-1 (Ang-1) increased in 4◦C PLTs over time, which was further enhanced by tubacin treatment. In addition, angiopoietin-2, an inducer of vascular leak and antagonist of Ang-1, inhibited PLT barrier protection, suggesting involvement of the Tie-2 pathway. This study demonstrates that HDAC-6 inhibition with tubacin attenuates the diminished vasculo-protective properties of 4◦C PLTs, and these properties may be independent of PLT circulation time.
AB - Platelets (PLTs) stored at 4◦C exhibit equivalent or superior hemostatic function compared with 22◦C PLTs, but have shorter circulation times and a decreased ability to modulate vascular permeability. These differences may be due to morphological changes and storage-induced activation. Using a proteomics-based approach, we found that 4◦C-stored PLTs express decreased α-tubulin, a key PLT structural protein. PLT activation is characterized by α-tubulin deacetylation, which is regulated by histone deacetylase-6 (HDAC-6). We hypothesized that inhibition of HDAC-6 in stored PLTs will improve their ability to regulate vascular permeability through reduced activation and α-tubulin deacetylation. In an in vivo model of vascular permeability, treatment of 4◦C PLTs with the HDAC-6 inhibitor tubacin enhanced the vasculoprotective properties of untreated 4◦C PLTs. 4◦C PLT circulation, however, was unchanged by tubacin treatment, suggesting that circulation time may not be a critical factor in determining the vasculoprotective effects of PLTs. Assessing the factor content of stored PLTs revealed that angiopoietin-1 (Ang-1) increased in 4◦C PLTs over time, which was further enhanced by tubacin treatment. In addition, angiopoietin-2, an inducer of vascular leak and antagonist of Ang-1, inhibited PLT barrier protection, suggesting involvement of the Tie-2 pathway. This study demonstrates that HDAC-6 inhibition with tubacin attenuates the diminished vasculo-protective properties of 4◦C PLTs, and these properties may be independent of PLT circulation time.
UR - http://www.scopus.com/inward/record.url?scp=85174822442&partnerID=8YFLogxK
U2 - 10.1182/BLOODADVANCES.2022007409
DO - 10.1182/BLOODADVANCES.2022007409
M3 - Article
C2 - 36375044
AN - SCOPUS:85174822442
SN - 2473-9529
VL - 7
SP - 1241
EP - 1257
JO - Blood Advances
JF - Blood Advances
IS - 7
ER -